If you could vote on Brexit now which option would you choose?
   

F.D.A. Clears Monoclonal Antibody Drug From Eli Lilly


With Covid treatments still in short supply in the United States, the Food and Drug Administration on Friday gave emergency authorization to a new monoclonal antibody drug that has been found in the laboratory to be potent against the Omicron variant of the coronavirus. The Biden administration said it would make the therapy immediately available to states free of charge. The authorization of the treatment, bebtelovimab, means that the United States now has four drugs available for high-risk Covid patients early in the course of their illness that have been found to neutralize the Omicron variant. While there is a greater menu of Covid pills and treatments now than at any other point in the pandemic, the drugs have been so scarce that doctors have been forced to make painful rationing decisions during the Omicron surge.

The New York Times - February 11, 2022

View the full story here: https://www.nytimes.com/2022/02/11/us/politics/eli-lilly-antibody-treatment-covid.html